Sickle cell: NICE approves voxelotor after initially rejecting it over uncertain evidence

BMJ. 2024 May 3:385:q1015. doi: 10.1136/bmj.q1015.
No abstract available

Publication types

  • News

MeSH terms

  • Anemia, Sickle Cell*
  • Antisickling Agents / therapeutic use
  • Benzaldehydes*
  • Drug Approval
  • Humans
  • Pyrazines / therapeutic use
  • Pyrazoles / therapeutic use
  • United Kingdom

Substances

  • voxelotor
  • Pyrazines
  • Pyrazoles
  • Antisickling Agents
  • Benzaldehydes